$644 Million is the total value of Eventide Asset Management's 101 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 16.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AGIO | Buy | AGIOS PHARMACEUTICALS INC | $17,782,000 | +255.6% | 454,200 | +117.5% | 2.76% | +79.1% |
MDVN | Buy | MEDIVATION INC | $17,026,000 | +97.9% | 264,500 | +96.2% | 2.64% | -0.3% |
CBI | Buy | CHICAGO BRIDGE & IRON CO N V | $16,890,000 | +96.5% | 193,800 | +87.4% | 2.62% | -1.0% |
TRW | Buy | TRW AUTOMOTIVE HLDGS CORP | $16,193,000 | +103.3% | 198,400 | +85.2% | 2.51% | +2.4% |
ABBV | Buy | ABBVIE INC | $14,793,000 | +88.6% | 287,800 | +93.8% | 2.30% | -5.0% |
MIC | Buy | MACQUARIE INFRASTR CO LLCmembership int | $14,615,000 | +92.2% | 255,200 | +82.7% | 2.27% | -3.2% |
UFS | Buy | DOMTAR CORP | $14,510,000 | +99.2% | 129,300 | +67.5% | 2.25% | +0.4% |
MGA | Buy | MAGNA INTL INC | $14,418,000 | +116.4% | 149,700 | +84.4% | 2.24% | +9.0% |
EOG | Buy | EOG RES INC | $14,203,000 | +123.9% | 72,400 | +91.5% | 2.20% | +12.8% |
PANW | Buy | PALO ALTO NETWORKS INC | $14,104,000 | +116.0% | 205,600 | +81.0% | 2.19% | +8.9% |
SUNEQ | Buy | SUNEDISON INC | $13,736,000 | +182.3% | 729,100 | +95.5% | 2.13% | +42.2% |
WBC | Buy | WABCO HLDGS INC | $13,554,000 | +104.4% | 128,400 | +80.8% | 2.10% | +3.0% |
LEA | Buy | LEAR CORP | $13,471,000 | +91.7% | 160,900 | +85.4% | 2.09% | -3.4% |
TEX | New | TEREX CORP NEW | $13,445,000 | – | 303,500 | +100.0% | 2.09% | – |
LLTC | Buy | LINEAR TECHNOLOGY CORP | $13,302,000 | +103.5% | 273,200 | +90.4% | 2.06% | +2.5% |
MEOH | Buy | METHANEX CORP | $12,871,000 | +79.6% | 201,300 | +66.4% | 2.00% | -9.5% |
ROC | New | ROCKWOOD HLDGS INC | $12,678,000 | – | 170,400 | +100.0% | 1.97% | – |
ININ | Buy | INTERACTIVE INTELLIGENCE GRO | $12,390,000 | +1126.7% | 170,900 | +1039.3% | 1.92% | +518.3% |
RHT | Buy | RED HAT INC | $12,307,000 | +73.9% | 232,300 | +83.9% | 1.91% | -12.4% |
LOW | Buy | LOWES COS INC | $11,853,000 | +81.5% | 242,400 | +83.9% | 1.84% | -8.5% |
DYAX | Buy | DYAX CORP | $11,476,000 | +47.1% | 1,278,000 | +23.3% | 1.78% | -25.9% |
PCYC | Buy | PHARMACYCLICS INC | $11,165,000 | +58.5% | 111,400 | +67.3% | 1.73% | -20.1% |
WAB | Buy | WABTEC CORP | $10,517,000 | +95.0% | 135,700 | +86.9% | 1.63% | -1.7% |
LYB | Buy | LYONDELLBASELL INDUSTRIES N | $10,130,000 | +53.3% | 113,900 | +38.4% | 1.57% | -22.7% |
FPRX | New | FIVE PRIME THERAPEUTICS INC | $10,090,000 | – | 513,200 | +100.0% | 1.57% | – |
LGND | Buy | LIGAND PHARMACEUTICALS INC | $9,948,000 | +40.7% | 147,900 | +10.0% | 1.54% | -29.1% |
STKL | Buy | SUNOPTA INC | $9,715,000 | +81.8% | 822,600 | +54.0% | 1.51% | -8.4% |
IPHI | Buy | INPHI CORP | $9,707,000 | +120.0% | 603,300 | +76.4% | 1.51% | +10.8% |
CCI | Buy | CROWN CASTLE INTL CORP | $9,643,000 | +193.1% | 130,700 | +191.7% | 1.50% | +47.6% |
PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $9,415,000 | +111.0% | 363,500 | +109.8% | 1.46% | +6.3% |
CMRX | New | CHIMERIX INC | $9,408,000 | – | 411,900 | +100.0% | 1.46% | – |
CXP | New | COLUMBIA PPTY TR INC | $9,151,000 | – | 335,800 | +100.0% | 1.42% | – |
CPN | Buy | CALPINE CORP | $8,868,000 | +52.8% | 424,100 | +42.6% | 1.38% | -23.0% |
ASML | Buy | ASML HOLDING N V | $8,757,000 | +79.7% | 93,800 | +80.4% | 1.36% | -9.5% |
P103PS | Buy | NPS PHARMACEUTICALS INC | $8,497,000 | +15.3% | 283,900 | +17.0% | 1.32% | -41.9% |
VMW | New | VMWARE INC | $8,490,000 | – | 78,600 | +100.0% | 1.32% | – |
SGMO | Buy | SANGAMO BIOSCIENCES INC | $8,362,000 | +177.1% | 462,500 | +112.8% | 1.30% | +39.6% |
NVAX | Buy | NOVAVAX INC | $7,886,000 | +19.6% | 1,740,900 | +35.2% | 1.22% | -39.7% |
CMRE | Buy | COSTAMARE INC | $7,744,000 | +142.6% | 360,200 | +106.2% | 1.20% | +22.3% |
AYR | Buy | AIRCASTLE LTD | $7,744,000 | +25.3% | 399,600 | +23.9% | 1.20% | -36.9% |
SDRL | Buy | SEADRILL LIMITED | $7,718,000 | +31.1% | 219,500 | +53.2% | 1.20% | -34.0% |
OII | Buy | OCEANEERING INTL INC | $7,466,000 | +15.7% | 103,900 | +27.0% | 1.16% | -41.7% |
STML | Buy | STEMLINE THERAPEUTICS INC | $7,378,000 | +80.9% | 362,400 | +74.1% | 1.14% | -8.9% |
SCTY | SOLARCITY CORP | $7,139,000 | +10.2% | 114,000 | 0.0% | 1.11% | -44.5% | |
BWA | BORGWARNER INC | $6,922,000 | +10.0% | 112,600 | 0.0% | 1.08% | -44.6% | |
KAR | KAR AUCTION SVCS INC | $6,452,000 | +2.7% | 212,600 | 0.0% | 1.00% | -48.2% | |
FC | Buy | FRANKLIN COVEY CO | $6,239,000 | +15.5% | 315,600 | +16.1% | 0.97% | -41.8% |
SRPT | Buy | SAREPTA THERAPEUTICS INC | $6,226,000 | +115.6% | 259,100 | +82.7% | 0.97% | +8.7% |
NRG | NRG ENERGY INC | $6,150,000 | +10.7% | 193,400 | 0.0% | 0.96% | -44.2% | |
NLNK | Buy | NEWLINK GENETICS CORP | $6,126,000 | +76.9% | 215,700 | +37.1% | 0.95% | -10.9% |
TSLA | Buy | TESLA MTRS INC | $5,482,000 | +155.0% | 26,300 | +83.9% | 0.85% | +28.5% |
AZPN | New | ASPEN TECHNOLOGY INC | $5,443,000 | – | 128,500 | +100.0% | 0.84% | – |
CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $5,101,000 | -18.0% | 288,700 | +12.3% | 0.79% | -58.7% |
PWR | Buy | QUANTA SVCS INC | $4,945,000 | +98.1% | 134,000 | +69.4% | 0.77% | -0.1% |
ACAD | Buy | ACADIA PHARMACEUTICALS INC | $4,708,000 | +7.4% | 193,500 | +10.3% | 0.73% | -45.9% |
PBYI | Buy | PUMA BIOTECHNOLOGY INC | $4,676,000 | +7.3% | 44,900 | +6.7% | 0.73% | -45.9% |
SJM | Buy | SMUCKER J M CO | $4,512,000 | +20.6% | 46,400 | +28.5% | 0.70% | -39.2% |
SZYM | Buy | SOLAZYME INC | $4,226,000 | +60.9% | 364,000 | +50.9% | 0.66% | -18.9% |
NOV | NATIONAL OILWELL VARCO INC | $3,699,000 | -2.1% | 47,500 | 0.0% | 0.57% | -50.7% | |
TTPH | Buy | TETRAPHASE PHARMACEUTICALS I | $3,277,000 | +150.9% | 300,900 | +211.5% | 0.51% | +26.6% |
ATRC | Buy | ATRICURE INC | $2,705,000 | +108.9% | 143,800 | +107.5% | 0.42% | +5.3% |
ECYT | Buy | ENDOCYTE INC | $2,333,000 | +377.1% | 98,000 | +114.4% | 0.36% | +139.7% |
PRTA | New | PROTHENA CORP PLC | $2,233,000 | – | 58,300 | +100.0% | 0.35% | – |
SLXP | Buy | SALIX PHARMACEUTICALS INC | $2,124,000 | +162.5% | 20,500 | +127.8% | 0.33% | +32.5% |
KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $2,094,000 | +208.8% | 67,800 | +129.1% | 0.32% | +55.5% |
CERN | New | CERNER CORP | $2,070,000 | – | 36,800 | +100.0% | 0.32% | – |
CBST | Buy | CUBIST PHARMACEUTICALS INC | $2,004,000 | +144.4% | 27,400 | +130.3% | 0.31% | +22.9% |
CLVS | New | CLOVIS ONCOLOGY INC | $1,960,000 | – | 28,300 | +100.0% | 0.30% | – |
SUPN | New | SUPERNUS PHARMACEUTICALS INC | $1,927,000 | – | 215,500 | +100.0% | 0.30% | – |
BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $1,917,000 | +162.2% | 28,100 | +170.2% | 0.30% | +32.4% |
SAAS | INCONTACT INC | $1,856,000 | +22.9% | 193,300 | 0.0% | 0.29% | -38.1% | |
HPTX | Buy | HYPERION THERAPEUTICS INC | $1,850,000 | +193.2% | 71,700 | +129.8% | 0.29% | +47.9% |
NTUS | Buy | NATUS MEDICAL INC DEL | $1,834,000 | +164.6% | 71,100 | +130.8% | 0.28% | +33.8% |
OMED | Buy | ONCOMED PHARMACEUTICALS INC | $1,777,000 | +167.6% | 52,800 | +134.7% | 0.28% | +34.6% |
BRKR | Buy | BRUKER CORP | $1,684,000 | +178.3% | 73,900 | +141.5% | 0.26% | +40.3% |
ACRX | Buy | ACELRX PHARMACEUTICALS INC | $1,674,000 | +179.5% | 139,400 | +163.0% | 0.26% | +40.5% |
CSII | Buy | CARDIOVASCULAR SYS INC DEL | $1,675,000 | +114.2% | 52,700 | +131.1% | 0.26% | +7.9% |
CEMP | Buy | CEMPRA INC | $1,654,000 | +107.5% | 143,200 | +122.7% | 0.26% | +4.5% |
FMI | Buy | FOUNDATION MEDICINE INC | $1,593,000 | +481.4% | 49,200 | +327.8% | 0.25% | +194.0% |
MGNX | Buy | MACROGENICS INC | $1,564,000 | +200.2% | 56,200 | +195.8% | 0.24% | +50.9% |
FEIC | Buy | FEI CO | $1,525,000 | +184.5% | 14,800 | +146.7% | 0.24% | +43.6% |
MEIP | Buy | MEI PHARMA INC | $1,515,000 | +204.8% | 136,100 | +119.2% | 0.24% | +53.6% |
BLUE | Buy | BLUEBIRD BIO INC | $1,478,000 | +174.2% | 65,000 | +152.9% | 0.23% | +38.0% |
SHPG | Buy | SHIRE PLCsponsored adr | $1,456,000 | +61.1% | 9,800 | +53.1% | 0.23% | -18.7% |
ATHN | Buy | ATHENAHEALTH INC | $1,426,000 | +165.1% | 8,900 | +122.5% | 0.22% | +33.1% |
NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $1,406,000 | +290.6% | 87,300 | +126.8% | 0.22% | +96.4% |
INSM | Buy | INSMED INC | $1,371,000 | +144.8% | 72,000 | +118.8% | 0.21% | +23.1% |
XOMA | Buy | XOMA CORP DEL | $1,340,000 | +63.8% | 257,200 | +111.5% | 0.21% | -17.5% |
AMBI | Buy | AMBIT BIOSCIENCES CORP | $1,196,000 | +67.5% | 131,100 | +76.9% | 0.19% | -15.5% |
COG | CABOT OIL & GAS CORP | $1,193,000 | -12.5% | 35,200 | 0.0% | 0.18% | -56.0% | |
MDSO | Buy | MEDIDATA SOLUTIONS INC | $1,027,000 | +21.1% | 18,900 | +35.0% | 0.16% | -39.1% |
PCRX | PACIRA PHARMACEUTICALS INC | $931,000 | +21.7% | 13,300 | 0.0% | 0.14% | -38.6% | |
ATHX | Buy | ATHERSYS INC | $860,000 | +94.1% | 265,300 | +49.8% | 0.13% | -1.5% |
RGEN | REPLIGEN CORP | $691,000 | -5.6% | 53,700 | 0.0% | 0.11% | -52.7% | |
MDAS | MEDASSETS INC | $655,000 | +24.8% | 26,500 | 0.0% | 0.10% | -37.0% | |
TFX | TELEFLEX INC | $622,000 | +14.3% | 5,800 | 0.0% | 0.10% | -42.3% | |
SNSS | SUNESIS PHARMACEUTICALS INC | $607,000 | +39.5% | 91,800 | 0.0% | 0.09% | -29.9% | |
CERS | CERUS CORP | $469,000 | -25.7% | 97,800 | 0.0% | 0.07% | -62.4% | |
RMD | RESMED INC | $442,000 | -5.2% | 9,900 | 0.0% | 0.07% | -52.1% | |
RPTP | RAPTOR PHARMACEUTICAL CORP | $404,000 | -23.2% | 40,400 | 0.0% | 0.06% | -61.1% | |
HTWR | HEARTWARE INTL INC | $291,000 | 0.0% | 3,100 | 0.0% | 0.04% | -50.0% | |
VVUS | Exit | VIVUS INC | $0 | – | -27,900 | -100.0% | -0.08% | – |
ONTX | Exit | ONCONOVA THERAPEUTICS INC | $0 | – | -23,000 | -100.0% | -0.08% | – |
DWSN | Exit | DAWSON GEOPHYSICAL CO | $0 | – | -65,300 | -100.0% | -0.68% | – |
Exit | ASPEN TECHNOLOGY INC | $0 | – | -128,500 | -100.0% | -1.66% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-13
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LOWES COS INC | 40 | Q3 2023 | 3.2% |
PALO ALTO NETWORKS INC | 40 | Q3 2023 | 3.6% |
ASML HOLDINGS NV | 40 | Q3 2023 | 1.9% |
NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
REPLIGEN CORP | 40 | Q3 2023 | 0.5% |
VERACYTE INC | 38 | Q3 2023 | 1.5% |
LAM RESEARCH CORP | 35 | Q3 2023 | 3.4% |
XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.6% |
MAGNA INTL INC | 33 | Q4 2021 | 2.5% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Cogent Biosciences, Inc. | February 14, 2023 | 2,589,778 | 3.7% |
ESSA Pharma Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Freeline Therapeutics Holdings plc | February 14, 2023 | 5,920,765 | 9.1% |
KnowBe4, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Praxis Precision Medicines, Inc. | February 14, 2023 | 3,518,062 | 7.5% |
Prometheus Biosciences, Inc. | February 14, 2023 | 1,032,938 | 2.2% |
SUTRO BIOPHARMA, INC.Sold out | February 14, 2023 | 0 | 0.0% |
Vital Farms, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Zymeworks Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Entasis Therapeutics Holdings Inc. | February 14, 2022 | 590,602 | 1.2% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-02-20 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.